Drug Profile
NS 11821
Alternative Names: NS11821Latest Information Update: 10 Mar 2017
Price :
$50
*
At a glance
- Originator NeuroSearch
- Class Anxiolytics
- Mechanism of Action GABA A receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Anxiety disorders; CNS disorders
Most Recent Events
- 08 Mar 2017 Discontinued - Phase-I for Anxiety disorders in Denmark (PO) before March 2017 (NeuroSearch website, March 2017) (NeuroSearch email communication, March 2017)
- 08 Mar 2017 Discontinued - Phase-I for CNS disorders in Denmark (PO) before March 2017 (NeuroSearch website, March 2017) (NeuroSearch email communication, March 2017)